Crystal structures of SgcE6 and SgcC, the two component monooxygenase that catalyzes hydroxylation of a carrier protein tethered substrate during the biosynthesis of the …

Chin-Yuan Chang,Jeremy R Lohman,Hongnan Cao,Kemin Tan,Jeffrey D Rudolf,Ming Ma,Weijun Xu,Craig A Bingman,Ragothaman M Yennamalli,Lance Bigelow,Gyorgy Babnigg,Xiaohui Yan,Andrzej Joachimiak,George N Phillips Jr,Ben Shen
IF: 3.321
2016-01-01
Biochemistry
Abstract:C-1027 is a chromoprotein enediyne antitumor antibiotic produced by Streptomyces globisporus. In the last step of biosynthesis of the (S)-3-chloro-5-hydroxy-β-tyrosine moiety of the C-1027 enediyne chromophore, SgcE6 and SgcC compose a two-component monooxygenase that hydroxylates the C-5 position of (S)-3-chloro-β-tyrosine. This two-component monooxygenase is remarkable for two reasons. (i) SgcE6 specifically reacts with FAD and NADH, and (ii) SgcC is active with only the peptidyl carrier protein (PCP)-tethered substrate. To address the molecular details of substrate specificity, we determined the crystal structures of SgcE6 and SgcC at 1.66 and 2.63 Å resolution, respectively. SgcE6 shares a similar β-barrel fold with the class I HpaC-like flavin reductases. A flexible loop near the active site of SgcE6 plays a role in FAD binding, likely by providing sufficient space to accommodate the AMP moiety of …
What problem does this paper attempt to address?